NASP Member EVERSANA’s Data & Analytics platform to be used by ICER to conduct indirect treatment comparisons to support value assessments

Jul 23, 2020 · NASP News

CHICAGO – July 23, 2020 – EVERSANA™, the leading provider of global commercial services to the life sciences industry, today announced a partnership with the Institute for Clinical and Economic Review (ICER) to advance standards for the usage of transparent, replicable and robust indirect treatment comparisons in health technology assessments.

Click here to read the EVERSANA / ICER press release.